AI Research and Policy Resources
This section will be updated on a regular basis
Artificial intelligence (AI) has enormous potential for strengthening the delivery of health care and medicine and helping all countries achieve universal health coverage. This includes improved diagnosis and clinical care, enhancing health research and drug development and assisting with the deployment of different public health interventions, such as disease surveillance, outbreak response, and health systems management.
This WHO guidance document is the result of a two-year development process led by two Departments in the Science Division - Digital Health and Innovation and Research For Health. WHO has worked with a leading group of twenty experts to identify core principles to promote the ethical use of AI for health - these are the first consensus principles in this field.
The European Commission published its Resource Page on Artificial Intelligence where it is going to collect all the most relevant news on Artificial Intelligence in the frame of European policies and regulations.
ICMRA Informal Innovation Network - Horizon Scanning Assessment Report - Artificial Intelligence (August 2021)
In this report, published in August 2021, the International Coalition of Medicines Regulatory Authorities (ICMRA) sets out recommendations to help regulators to address the challenges that the use of artificial intelligence (AI) poses for global medicines regulation.